Performance characteristics of recombinant enzyme immunoassay to detect antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 and to measure early antibody responses in seroconverting patients

Journal of Clinical Microbiology

Volumn 34, Issue 4, 1996, Pages 999-1002

  Galli, Richard A ^a   Castriciano, Santina ^b   Fearon, Margaret ^a   Major, Carol ^a   Choi, Kam Wing ^a   Mahony, Jim ^b   Chernesky, Max ^b  

^a ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; DIAGNOSTIC ACCURACY; ELECTROIMMUNOASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROCONVERSION; STRAIN DIFFERENCE; VIRUS DETECTION;

EVALUATION STUDIES; GENE PRODUCTS, ENV; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV SEROPOSITIVITY; HIV-1; HIV-2; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0029937752     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.4.999-1002.1996     Document Type: Article

References (18)

1. Albert, J., F. Bredberg, F. Chiodi, B. Bottiger, E. Fenyo, E. Norrby, and G. Biberfield. 1987. A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res. Hum. Retroviruses 3:3-10.
2. Busch, M. P., L. L. L. Lee, G. A. Satten, D. R. Henrard, H. Farzadegan, K. Nelson, S. Read, R. Y. Dodd, and L. R. Petersen. 1995. Time course of detection of viral and serologie markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 35:91-97.
3. Busch, M. P., L. Peterson, C. Schable, and H. Perkins. 1990. Monitoring blood donors for HIV-2 infection by testing anti-HIV-1 reactive sera. Transfusion 30:184-187.
4. De Cock, K. M., A. Porter, J. Kouadio, M. Maran, E. Gnaore, G. Adjorlolo, M. Lafontaine, G. Bretton, G. Gershy Danet, K. Odehouri, J. R. George, and W. L. Heyward. 1990. Rapid and specific diagnosis of HIV-1 and HIV-2 infections: an evaluation of testing strategies. AIDS 4:875-878.
5. Epstein, J., R. Gregg, A. Saah, et al. 1987. Western blot analysis of serial IgG, IgM and IgA responses to the human immunodeficiency virus (HIV) in recent seroconverters, abstr. 131 In III International Conference on acquired Immunodeficiency Syndrome (AIDS). Bio-data, Washington, D C.
6. Gallarda, J. L., D. R. Hernard, D. Liu, S. Harrington, S. Stramer, J. E. Valinsky, and P. Wu. 1992. Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody. J. Clin. Microbiol. 30: 2379-2384.
7. Guyader, M., M. Emerman, P. Sonigo, F. Clavel, L. Montagnier, and M. Alizon. 1987 Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (London) 326:662-669.
8. Holloman, D. L., C. P. Pau, B. Parekh, C. Schable, I. Onorato, G. Schochetman, and J. R. George. 1993. Evaluation of testing algorithms following the use of combination HIV-l/HIV-2 EIA for screening purposes. AIDS Res Hum. Retroviruses 9:147-151.
9. Johnson, J. E. 1992 Detection of human immunodeficiency virus type 1 antibody by using commercially available whole-cell viral lysate, synthetic peptide, and recombinant protein enzyme immunoassay systems. J. Clin. Microbiol. 30:216-218.
10. Lange, J., J. Parry, F. deWolf, P. P. Mortimer, and J. Goudsmit. 1988. Diagnostic value of specific IgM antibodies in primary HIV infection. AIDS 2:31-35.
11. Neumann, P. W., B. Benning, D. Robinson, N. Gilmore, and M. O'Shaughnessy. 1986. HTLV-III infection in Canada in 1985. Can. Med. Assoc. J. 135:477-480.
12. Neumann, P. W., M. V. O'Shaughnessy, D. Lepine, I. D'Souza, C. Major, and B. McLaughlin. 1989. Laboratory diagnosis of the first case of HIV-2 infection in Canada. Can. Med. Assoc. J. 140:125-128.
13. O'Brien, T. R., J. R. George, and S. D. Holmberg. 1992. Human immunodeficiency virus type 2 in the United States epidemiology, diagnosis, and public health implications. JAMA 267:2775-2779.
14. Palomba, E., V. Gay, M. DeMartino, C. Fundarco, L. Perugini, and P. A. Tova. 1992. Early diagnosis of human immunodeficiency virus infection in infants by detection of free and complexed p24 antigen. J. Infect Dis. 165:394-395.
15. Parry, J. V., L. McAlpine, and M. F. Avilley. 1990. Sensitivity of six commercial enzyme immunoassay kits that detect both anti-HIV-1 and HIV-2. AIDS 4:355-360.
16. Smith, R. S., and D. E. Parks. 1990. Synthetic peptide assays to detect human immunodeficiency virus types 1 and 2 in seropositive individuals. Arch. Pathol. Lab. Med. 114:254-258.
17. Sprengers, E. D., J. A. Hellings, H. J. Theunissen, and P. B. Ten Kortenaar. 1991. A microELISA system for the detection of both anti-HIV-1 and anti-HIV-2 antibodies. J. Immunol. Methods 139:77-82.
18. Zaaijer, H. L., P. V. Exel-Oehlers, and T. Kraaijeveld. 1992. Early detection of antibodies to HIV-1 by third-generation assays. Lancet 340:770-772.